Northern Trust Corp Biogen Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Biogen Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,425,921 shares of BIIB stock, worth $276 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,425,921

Previous 1,388,386 2.7%

Holding current value

$276 Million

Previous $299 Million 10.41%

% of portfolio

0.06%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $7.15 Million - $8.89 Million	37,535 Added 2.7%	1,425,921 $331 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $22.6 Million - $28.5 Million	-106,577 Reduced 7.13%	1,388,386 $299 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $33 Million - $39.7 Million	-148,072 Reduced 9.01%	1,494,963 $387 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $11.5 Million - $13 Million	45,437 Added 2.84%	1,643,035 $422 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $20.3 Million - $23.4 Million	-73,691 Reduced 4.41%	1,597,598 $455 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $97,492 - $111,089	-380 Reduced 0.02%	1,671,289 $465 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $3.37 Million - $4.1 Million	-13,352 Reduced 0.79%	1,671,669 $463 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $4.78 Million - $6.59 Million	-24,556 Reduced 1.44%	1,685,021 $450 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $4.51 Million - $5.36 Million	24,050 Added 1.43%	1,709,577 $349 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $1.28 Million - $1.61 Million	-6,595 Reduced 0.39%	1,685,527 $355 Million
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $15 Million - $19.2 Million	-66,768 Reduced 3.8%	1,692,122 $406 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $87.3 Million - $114 Million	-308,649 Reduced 14.93%	1,758,890 $498 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $13.7 Million - $22 Million	-52,969 Reduced 2.5%	2,067,539 $716 Million
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $19.5 Million - $22.9 Million	-80,450 Reduced 3.66%	2,120,508 $593 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $43.1 Million - $64.8 Million	-182,232 Reduced 7.65%	2,200,958 $539 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $14.4 Million - $16.6 Million	-54,446 Reduced 2.23%	2,383,190 $676 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $8.58 Million - $11.4 Million	-33,166 Reduced 1.34%	2,437,636 $652 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $5.5 Million - $6.98 Million	-20,459 Reduced 0.82%	2,470,802 $782 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $66.3 Million - $91.6 Million	-301,394 Reduced 10.79%	2,491,261 $739 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $19.6 Million - $22 Million	-90,235 Reduced 3.13%	2,792,655 $650 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $3.57 Million - $3.93 Million	-16,277 Reduced 0.56%	2,882,890 $674 Million
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $1.76 Million - $2.76 Million	-8,139 Reduced 0.28%	2,899,167 $685 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $37.1 Million - $47 Million	133,137 Added 4.8%	2,907,306 $875 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $34.7 Million - $45.4 Million	-118,390 Reduced 4.09%	2,774,169 $980 Million
Q2 2018 Sep 18, 2018	SELL	$257.52 - $306.91 $3.62 Million - $4.31 Million	-14,055 Reduced 0.48%	2,892,559 $840 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $8.7 Million - $10.4 Million	33,785 Added 1.18%	2,906,614 $844 Million
Q1 2018 May 09, 2018	SELL	$260.13 - $367.91 $27.7 Million - $39.2 Million	-106,511 Reduced 3.57%	2,872,829 $787 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $15.2 Million - $17 Million	-49,407 Reduced 1.63%	2,979,340 $949 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $852 Million - $999 Million	3,028,747	3,028,747 $948 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Biogen Inc. Transaction History